Medchemexpress LLC 4-[2-[4-(2-pyridin-2-yl-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl]oxyethyl]morpholine | 700874-71-1 | ≥98.0% | 50 MG

Supplier:  Medchemexpress LLC HY1207550MG

LY2109761 is an orally active small-molecule dual inhibitor of transforming growth factor-β (TGF-β) receptor type I and II used for research applications. It shows Ki values of 38 nM for TβRI and 300 nM for TβRII, and is supplied as a powder for analytical and research use.

• Orally active TGF-β receptor type I/II inhibitor
• Ki values of 38 nM (TβRI) and 300 nM (TβRII)
• Powder form suitable for analytical and research use
• Molecular formula C26H27N5O2; molecular weight 441.52 g/mol
• Soluble in DMSO (6.67 mg/mL) and suspendable in 0.5% CMC-Na/0.5% Tween-80 (1 mg/mL)
• Stable when stored as a powder at -20°C for long-term storage

Catalog No. 50-002-30119